164 related articles for article (PubMed ID: 9731890)
1. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.
Durand-Zaleski I; Earlam S; Fordy C; Davies M; Allen-Mersh TG
Cancer; 1998 Sep; 83(5):882-8. PubMed ID: 9731890
[TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
4. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
[TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial chemotherapy in metastatic colorectal patients.
Kemeny NE; Ron IG
Semin Oncol; 1999 Oct; 26(5):524-35. PubMed ID: 10528900
[TBL] [Abstract][Full Text] [Related]
7. [Systemic chemotherapy for advanced colorectal cancer with liver metastasis].
Hasuike Y; Takeda Y; Mishima H; Nishishou I; Tsujinaka T; Kikkawa N
Gan To Kagaku Ryoho; 2002 Jun; 29(6):866-72. PubMed ID: 12090037
[TBL] [Abstract][Full Text] [Related]
8. [Locoregional chemotherapy of liver metastasis from colorectal carcinoma].
Zamparelli G; Pancera G; Pessi MA; Dallavalle G; Pirovano M; Valsecchi R; Labianca R; Samori G; Luporini G
Ann Ital Chir; 1996; 67(6):793-7. PubMed ID: 9214270
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
Seki H; Ozaki T; Shiina M
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.
Barber FD; Mavligit G; Kurzrock R
Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic arterial infusion chemotherapy for colorectal liver metastases].
Kumada T; Sone Y; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kuzuya T; Nonogaki K; Shimizu J; Yamauti T; Kawase N
Gan To Kagaku Ryoho; 2004 May; 31(5):700-5. PubMed ID: 15170976
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness in the management of patients with oesophageal cancer.
Farndon MA; Wayman J; Clague MB; Griffin SM
Br J Surg; 1998 Oct; 85(10):1394-8. PubMed ID: 9782023
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
Martin RC; Scoggins CR; McMasters KM
J Surg Oncol; 2006 Apr; 93(5):387-93. PubMed ID: 16550574
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.
Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M
In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
Fujimoto T; Yoshimatsu K; Yokomizo H; Umehara A; Watanabe K; Ohtani T; Matsumoto A; Ohsawa G; Ishibashi K; Ogawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1838-40. PubMed ID: 17212122
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N
Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
